Evidence map›Paper›PMID 31888465›Full record

ArticleBMC immunology2019

Amentoflavone ameliorates cold stress-induced inflammation in lung by suppression of C3/BCR/NF-κB pathways.

Jiayi Cai, Chunyang Zhao, Yajie Du, Yuan Huang, Qingchun Zhao

Open access · goldAbstract read
In one paragraph

Article in BMC immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Therapeutic Potential ofInternational journal of molecular sciences · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Potential of amentoflavone with antiviral properties in COVID-19 treatment.Asian biomedicine : research, reviews and news · 2021
    Review
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jiayi CaiSchool of Life Sciences and Biopharmaceutis, Shenyang Pharmaceutical University, Shenyang, 110016, China. caijiayi_syphu@163.com.ORCID 0000-0001-5901-1466
Chunyang ZhaoCollege of Pharmaceutical Science, China Medical University, Shenyang, 110122, China.
Yajie DuSchool of Life Sciences and Biopharmaceutis, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Yuan HuangSchool of Life Sciences and Biopharmaceutis, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Qingchun ZhaoSchool of Life Sciences and Biopharmaceutis, Shenyang Pharmaceutical University, Shenyang, 110016, China. zhaoqingchun1967@163.com.
Shenyang Pharmaceutical University · CNFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCold stress, which may lead to local and systemic injury, is reported to be related to the immune system, especially the complement system. At present, the lack of effective treatment is a critical issue. Amentoflavone (AF), which can inhibit cold stress-induced inflammation in lung by multiple mechanisms, is the main therapeutic ingredient in plants of the genus Selaginella.

resultsIn the current study, we found that cold could induce lung inflammation related to the complement system and its downstream pathways. AF treatment significantly inhibited lung inflammation from cold exposure. We presented evidence that AF can bind to complement component 3 (C3) to regulate inflammation-related pathways involving Lck/Yes novel tyrosine kinase (Lyn), protein kinase B (Akt), nuclear factor-κB (NF-κB) and immune factors. Moreover, 30 mg/kg of AF caused significantly greater improvement than 15 mg/kg in reducing the level of C3 in lung tissue.

conclusionsAF can protect lung tissue from cold exposure. The protective effect may be achieved by inhibition of C3 and negative regulation of the B cell receptor (BCR)/NF-κB signaling pathways and high mobility group box 1 (HMGB1), which ultimately ameliorates the inflammatory response.

Indexed as

AnimalsBiflavonoidsBiomarkersBiopsyCold-Shock ResponseComplement C3Disease Models, AnimalHemodynamicsHMGB1 ProteinMaleNF-kappa BPneumoniaRatsReceptors, Antigen, B-CellRegional Blood FlowamentoflavoneBiflavonoidsBiomarkersComplement C3HMGB1 ProteinNF-kappa BReceptors, Antigen, B-CellAmentoflavoneCold stressComplement C3InflammationLung

Identifiers

PMID31888465
PMCPMC6937961
OpenAlexW2998123293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.